A7V (p.Ala7Val) variant of HTR2C (5-hydroxytryptamine receptor 2C)

A7V (p.Ala7Val) in HTR2C (5-hydroxytryptamine receptor 2C) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.12 / 1. The record also includes population frequency data and structural context.

A7V (p.Ala7Val) variant details